EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct bacterial profiles according to structural lung disease in patients undergoing bronchial artery embolization for hemoptysis

Ui Won Ko, Mihyeon Heo, Suyoung Park, Jung Han Hwang, Beomsu Shin

Frontiers in Medicine · 29.05.2026 · 13

DOI: 10.3389/fmed.2026.1852948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 29.05.2026. Verfasst von Ui Won Ko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Pulmonology and Critical Care Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemoptysis frequently prompts emergency bronchial artery embolization (BAE), and bacterial infection is a common and modifiable trigger. As structural lung disease shapes airway microbiology, pathogen profiles may differ according to the structural lung disease phenotype and could inform empiric antibiotic selection in patients undergoing BAE.

Methods

We retrospectively reviewed consecutive patients who underwent BAE for hemoptysis at a tertiary referral center between January 2021 and December 2025. Structural lung disease was stratified into three categories based on computed tomography findings: (1) absence of structural lung disease, (2) bronchiectasis, or (3) emphysema/interstitial lung disease (ILD). Respiratory specimens (sputum or bronchial washing fluid) were evaluated using standard cultures and multiplex polymerase chain reaction (mPCR), when ordered clinically.

Results

A total of 188 patients were included [absence of structural lung disease ( n = 70), bronchiectasis ( n = 96), or emphysema/ILD ( n = 22)]. Overall, 77 patients (41.0%) showed ositive culture or mPCR results. The most commonly identified bacteria were Streptococcus pneumoniae (14.3%) in patients without structural lung disease, Pseudomonas aeruginosa (29.2%) in patients with bronchiectasis, and Klebsiella pneumoniae subsp. pneumoniae (18.2%) in patients with emphysema/ILD. P. aeruginosa was more frequent in patients with bronchiectasis than in those without structural lung disease (29.2% vs. 1.4%, P < 0.001). K. pneumoniae was detected more frequently in 18.2% of patients with emphysema/ILD and in 5.7% of those without structural lung disease ( P = 0.090).

Conclusion

Patients who underwent BAE showed distinct bacterial profiles according to their underlying structural lung disease. These differences may suggest that tailoring empiric antibiotics according to the structural lung disease phenotype could be considered when an infection is suspected in patients with hemoptysis.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosabronchiectasisembolizationhemoptysismicrobiologypolymerase chain reaction

Autor:innen und Institutionen

  • Department of Allergy, Pulmonology and Critical Care Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  • Department of Radiology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.

Zitieren

APA

Ko, U. W., Heo, M., Park, S., Hwang, J. H., & Shin, B. (2026). Distinct bacterial profiles according to structural lung disease in patients undergoing bronchial artery embolization for hemoptysis. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1852948

Vancouver

Ko UW, Heo M, Park S, Hwang JH, Shin B. Distinct bacterial profiles according to structural lung disease in patients undergoing bronchial artery embolization for hemoptysis. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1852948

BibTeX
@article{Ko2026,
  author = {Ko, Ui Won and Heo, Mihyeon and Park, Suyoung and Hwang, Jung Han and Shin, Beomsu},
  title = {Distinct bacterial profiles according to structural lung disease in patients undergoing bronchial artery embolization for hemoptysis},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1852948}
}
Kostenlos starten →